Navigation Links
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
Date:6/22/2008

om normal to high at any time was 11.9 percent.

At the time of the interim analysis of HGKB, 23 PDSS events were reported in 22 patients. Between 30 September, 2007 and 31 May, 2008, four additional events have been reported in this ongoing trial.

About Long-acting Injectable Antipsychotic Medications

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines state that poor or partial treatment compliance is a major problem in the long-term treatment of schizophrenia. Depot formulations should be considered as a treatment option when a patient expresses a preference for such treatment due to convenience or if it is determined that a depot formulation is necessary to help avoid nonadherence to oral medications.(i)

Long-acting antipsychotic formulations have been associated with improved treatment adherence and reduced treatment failures.(ii) By administering long-acting medications, healthcare professionals know when patients have received their medication and can immediately detect non-adherence when a patient fails to return for a scheduled injection.(iii) Different from both oral and injected short-acting formulations, long-acting formulations of antipsychotics allow for stable concentrations of the active drug to remain at a therapeutic range for an extended period of time.(iv)

About Schizophrenia

Schizophrenia is a severe and debilitating illness with symptoms such as delusions (false beliefs that cannot be corrected by reason), hallucinations (usually in the form of non-existent voices or visions), disorganized speech and severe disorganized or catatonic behavior. These signs and symptoms are associated with marked social or occupational dysfunction. Features of schizophrenia consist of characteristic signs and symptoms that have been present for a significant portion of time during a one-month period, with some signs of the disorder persisting for at least six months.(v) In addition to these symptom
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
2. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
3. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
4. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
5. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
6. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
7. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
8. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
9. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
10. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
11. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... N.J. , March 6, 2015  Palatin Technologies, Inc. ... at the 27 th Annual ROTH Conference on Wednesday, ... will be held at the Ritz Carlton Laguna Niguel in ... Carl Spana , Ph.D., President and Chief Executive Officer ... and development programs. About Palatin Technologies, ...
(Date:3/6/2015)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: CNAT ).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On March 5, 2015, the Company abruptly announced in ...
(Date:3/6/2015)... , March 6, 2015  The onset of puberty ... as well as clumsier, and thus more inclined toward a ... during puberty, while the body,s center of gravity is altered. ... hands often grow more quickly than the rest of the ... of height in single year. And while these sudden changes ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Puberty can result in variety of athletic injuries 2
... PLAINFIELD, N.J., Dec. 22 PTC Therapeutics, Inc. (PTC) ... round was led by The Column Group - a new investor ... joined by current investors Credit Suisse First Boston, HBM BioVentures, Novo ... with the Delphi investment, general partner Deepa Pakianathan, Ph.D. will join ...
... Minn., Dec. 21 Envoy Medical, a Minnesota corporation, has ... the Esteem®. On December 18th, an Advisory Panel ... the Esteem®. , Patrick Spearman, Envoy Medical,s Chief ... for all sensorineural hearing loss sufferers. Envoy has been ...
Cached Medicine Technology:PTC Therapeutics Closes $50 Million Financing 2
(Date:3/6/2015)... 2015 Today, the California Healthcare Institute ... M.D., Ph.D., Director of the National Institutes of Health ... for a roundtable discussion regarding the vibrancy of the ... President Obama's Precision Medicine Initiative. , Joint Statement from ... Dean of the School of Medicine, UC San Diego; ...
(Date:3/6/2015)... Mediaplanet today announces distribution of its ... seeks to educate, encourage, and inspire women to take ... health and their health care rights. With gynecological cancer ... more pertinent to prioritize well-woman exams and stand up ... of “Women’s Health” is distributed within this weekend’s edition ...
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 Dr. ... has been seeking a ban on the use of power ... a recurrence of the cancer that prompted the launch of ... earlier this week that the 41-year-old mother of six ... the bony part in her spine. Dr. Reed had been ...
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... March 06, 2015 Sanjay Gupta, ... deliver a keynote address at ATA 2015, the ... and Trade Show and world’s largest telemedicine, telehealth ... neurosurgeon, delivers medical correspondence for several of CNN’s ... and documentaries including his DuPont Award winning WEED ...
Breaking Medicine News(10 mins):Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 2Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 3Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 3Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 4Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2
... In international study has found that people in their ... five years longer than those with hypertension or high ... had normal blood pressure developed heart disease later in ... has been published in the current issue of Hypertension: ...
... research had showed that patients who are depressed and ... having another heart attack is lessened considerably with the ... often treat clinical depression, also known as unipolar depression, ... SSRIs are a group of drugs that can increase ...
... have less back pain from osteoporosis related// curving of the ... special exercises. ,In a study presented by the researchers ... back support device can not only decrease the back pain ... women who had suffered the disease. ,Elderly population remains ...
... by the ‘Delhi High Court’ on Tuesday Justice Vikramjit Sen passed ... 12 year old for the wrong treatment administered by Dr ... the next few days how much compensation was the hospital ready ... indicated that the operation for total hip replacement and fixation of ...
... from Children's Hospital Boston suggests that a urine test ... anomalies. The study also raises the possibility of treating ... of the journal - Pediatrics, has published an article ... found in about 10% of newly born infants and ...
... who have television in their bedroom may score less in ... TV in their rooms. In a new study by the ... Stanford University researchers have reported that the home environment, especially ... their ability to affect the performance of children in school. ...
Cached Medicine News:Health News:Normal Blood Pressure Could Add Over 5 Years To Your Life 2Health News:Simple Urine Test Can Help To Monitor Disfiguring Birthmarks, 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Extremely fine straight....
Curved delicate 5 mm blades....
Medicine Products: